{"id":"https://openalex.org/W1979978322","doi":"https://doi.org/10.2217/bmm.12.51","title":"Use of FDG PET as an Imaging Biomarker in Clinical Trials of Alzheimer\u2019s Disease","display_name":"Use of FDG PET as an Imaging Biomarker in Clinical Trials of Alzheimer\u2019s Disease","alternate_titles":[],"publication_year":2012,"publication_date":"2012-08-01","ids":{"openalex":"https://openalex.org/W1979978322","doi":"https://doi.org/10.2217/bmm.12.51","mag":"1979978322","pmid":"https://pubmed.ncbi.nlm.nih.gov/22917145"},"language":"en","primary_location":{"id":"doi:10.2217/bmm.12.51","doi":"https://doi.org/10.2217/bmm.12.51","is_oa":false,"landing_page_url":"https://doi.org/10.2217/bmm.12.51","pdf_url":null,"source":{"id":"https://openalex.org/S130557755","display_name":"Biomarkers in Medicine","issn_l":"1752-0363","issn":["1752-0363","1752-0371"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomarkers in Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1979978322"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053401725","display_name":"Karl Herholz","orcid":"https://orcid.org/0000-0002-8658-0151","observed_orcids":["https://orcid.org/0000-0002-8658-0151"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Karl Herholz","raw_affiliation_strings":["The University of Manchester, Wolfson Molecular Imaging Centre, 27 Palatine Road,Manchester, M20 3LJ, UK","The University of Manchester, Wolfson Molecular Imaging Centre, 27 Palatine Road, Manchester, UK. karl.herholz@manchester.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Manchester, Wolfson Molecular Imaging Centre, 27 Palatine Road,Manchester, M20 3LJ, UK","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"The University of Manchester, Wolfson Molecular Imaging Centre, 27 Palatine Road, Manchester, UK. karl.herholz@manchester.ac.uk","institution_ids":["https://openalex.org/I28407311"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5053401725"],"corresponding_institution_ids":["https://openalex.org/I28407311"],"apc_list":null,"apc_paid":null,"fwci":0.7188,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.57256778,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"6","issue":"4","first_page":"431","last_page":"439"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fdg-pet","display_name":"FDG-PET","score":0.996999979019165},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8529999852180481},{"id":"https://openalex.org/keywords/imaging-biomarkers","display_name":"imaging biomarkers","score":0.9150000214576721},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.8360000252723694},{"id":"https://openalex.org/keywords/early-diagnosis","display_name":"early diagnosis","score":0.6159999966621399},{"id":"https://openalex.org/keywords/disease-progression-monitoring","display_name":"disease progression monitoring","score":0.9259999990463257},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.878000020980835},{"id":"https://openalex.org/keywords/outcome-measurement","display_name":"outcome measurement","score":0.7829999923706055},{"id":"https://openalex.org/keywords/regional-glucose-metabolism","display_name":"regional glucose metabolism","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8844610452651978},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7351404428482056},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.732684314250946},{"id":"https://openalex.org/C45664433","wikidata":"https://www.wikidata.org/wiki/Q17029420","display_name":"Imaging biomarker","level":3,"score":0.6530966758728027},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6007477641105652},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.5446473956108093},{"id":"https://openalex.org/C3017724952","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Pet imaging","level":3,"score":0.52641361951828},{"id":"https://openalex.org/C58693492","wikidata":"https://www.wikidata.org/wiki/Q551875","display_name":"Neuroimaging","level":2,"score":0.4317014217376709},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3484812378883362},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.3279019892215729},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27499547600746155},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.26370716094970703},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.20563656091690063},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019788","descriptor_name":"Fluorodeoxyglucose F18","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2217/bmm.12.51","doi":"https://doi.org/10.2217/bmm.12.51","is_oa":false,"landing_page_url":"https://doi.org/10.2217/bmm.12.51","pdf_url":null,"source":{"id":"https://openalex.org/S130557755","display_name":"Biomarkers in Medicine","issn_l":"1752-0363","issn":["1752-0363","1752-0371"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomarkers in Medicine","raw_type":"journal-article"},{"id":"pmid:22917145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22917145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomarkers in medicine","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/7dedba39-eab7-437f-97b6-f6a55ab95655","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/7dedba39-eab7-437f-97b6-f6a55ab95655","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Herholz, K 2012, 'Use of FDG PET as an imaging biomarker in clinical trials of Alzheimers disease', Biomarkers in Medicine, vol. 6, no. 4, pp. 431-439. https://doi.org/10.2217/bmm.12.51","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332457","display_name":"GE Healthcare","ror":"https://ror.org/03yt24h27"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W1529577194","https://openalex.org/W1566965501","https://openalex.org/W1607330203","https://openalex.org/W1888183027","https://openalex.org/W1964964168","https://openalex.org/W1967008186","https://openalex.org/W1969787718","https://openalex.org/W1983349802","https://openalex.org/W1988693860","https://openalex.org/W1990181857","https://openalex.org/W2002996527","https://openalex.org/W2008622181","https://openalex.org/W2013207729","https://openalex.org/W2015904620","https://openalex.org/W2017831328","https://openalex.org/W2018353747","https://openalex.org/W2021686324","https://openalex.org/W2023760701","https://openalex.org/W2025152196","https://openalex.org/W2035183926","https://openalex.org/W2036267254","https://openalex.org/W2038389538","https://openalex.org/W2040490831","https://openalex.org/W2042557239","https://openalex.org/W2044832776","https://openalex.org/W2058202296","https://openalex.org/W2061807292","https://openalex.org/W2070060129","https://openalex.org/W2071607346","https://openalex.org/W2072361983","https://openalex.org/W2073332982","https://openalex.org/W2078563723","https://openalex.org/W2086710228","https://openalex.org/W2087880221","https://openalex.org/W2090538982","https://openalex.org/W2094554393","https://openalex.org/W2094784513","https://openalex.org/W2099489910","https://openalex.org/W2106931873","https://openalex.org/W2108453299","https://openalex.org/W2111709425","https://openalex.org/W2115017507","https://openalex.org/W2116649573","https://openalex.org/W2117164994","https://openalex.org/W2117175468","https://openalex.org/W2122632568","https://openalex.org/W2132680220","https://openalex.org/W2138904731","https://openalex.org/W2141408870","https://openalex.org/W2144631174","https://openalex.org/W2145369117","https://openalex.org/W2148677316","https://openalex.org/W2150300328","https://openalex.org/W2152060070","https://openalex.org/W2153284686","https://openalex.org/W2154394735","https://openalex.org/W2155277084","https://openalex.org/W2321904707","https://openalex.org/W2582524520"],"related_works":["https://openalex.org/W2037787270","https://openalex.org/W2595223864","https://openalex.org/W2752420858","https://openalex.org/W2148677316","https://openalex.org/W1964146457","https://openalex.org/W1973187309","https://openalex.org/W4409680093","https://openalex.org/W2327186385","https://openalex.org/W2003652996"],"abstract_inverted_index":{"PET":[0,100,129,149],"with":[1],"the":[2,21,37,56,141],"glucose":[3],"analog":[4],"FDG":[5,64,99,128,148],"as":[6,72,150],"a":[7,10,92,133],"tracer":[8],"is":[9,28],"mature":[11],"and":[12,45,55,80,98,105],"increasingly":[13],"available":[14],"clinical":[15,40,62,85,96,155],"imaging":[16,74,152],"technique":[17],"that":[18,138],"can":[19,48],"improve":[20],"diagnostic":[22],"accuracy":[23],"for":[24,76,108,121,144],"Alzheimer's":[25,53],"disease,":[26,54],"which":[27],"of":[29,36,52,78,82,117,123,136,147],"particular":[30],"value":[31],"at":[32],"an":[33,73,151],"early":[34],"stage":[35],"disease":[38],"when":[39],"symptoms":[41],"are":[42,58],"still":[43],"mild":[44],"nonspecific.":[46],"It":[47],"also":[49,68],"monitor":[50],"progression":[51],"findings":[57],"closely":[59],"related":[60],"to":[61],"symptoms.":[63],"PET,":[65],"therefore,":[66],"could":[67,139],"potentially":[69],"be":[70],"used":[71,107],"biomarker":[75,153],"selection":[77],"patients":[79],"assessment":[81],"outcome":[83,97],"in":[84,154],"trials.":[86,156],"Several":[87],"published":[88],"intervention":[89],"studies":[90,137],"indicate":[91],"good":[93],"correspondence":[94],"between":[95],"findings,":[101],"but":[102],"study":[103],"designs":[104],"methods":[106,120],"data":[109],"analysis":[110],"vary":[111],"widely.":[112],"Recent":[113],"developments":[114],"towards":[115],"standardization":[116],"largely":[118],"user-independent":[119],"quantification":[122],"regional":[124],"metabolic":[125],"impairment":[126],"on":[127],"scans":[130],"will":[131],"allow":[132],"new":[134],"generation":[135],"provide":[140],"required":[142],"evidence":[143],"full":[145],"qualification":[146]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1979978322","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":7}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
